arrow
M

Marcin Waligóra

collegium medicum jagiellonian university
H指数:15
被引数:775

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of catheter-directed mechanical thrombectomy in patients with cancer-associated pulmonary embolism: a multicenter, prospective registry

肿瘤相关肺栓塞患者经导管机械性血栓切除术的结局:一项多中心、前瞻性登记研究

2026-08-011
PRE
Clinically Actionable Explainable AI in Pulmonary Arterial Hypertension: Endpoints, Calibration, and External Validation. Reply to Pagnoni et al. Toward Clinically Actionable Explainable AI in Pulmonary Arterial Hypertension: Endpoints, Calibration, and External Validation. Comment on “Ledziński et al. Personalized Medicine in Pulmonary Arterial Hypertension: Utilizing Artificial Intelligence for Death Prevention. J. Clin. Med. 2025, 14, 8325”

临床可行的可解释人工智能在肺动脉高压中的应用:终点、校准与外部验证。回复Pagnoni等人。迈向临床可行的可解释人工智能在肺动脉高压中的应用:终点、校准与外部验证。评论“Ledziński等人。肺动脉高压中的个性化医学:利用人工智能预防死亡。J. Clin. Med. 2025, 14, 8325”。

2026-02-280
OAAI
The prevalence and long-term response to calcium channel blockers in patients with pulmonary arterial hypertension and positive vasoreactivity test – results of multicenter national registry (BNP-PL)

钙通道阻滞剂在肺动脉高压且血管反应性试验阳性患者中的使用普及率及长期疗效——多中心国家注册研究(BNP-PL)的结果

2026-02-250
OAAI
Personalized Medicine in Pulmonary Arterial Hypertension: Utilizing Artificial Intelligence for Death Prevention

肺动脉高压中的个性化医学:利用人工智能预防死亡

2025-11-230
OAAI
Response

响应

CHEST
IF8.6
2025-06-100
PRE
Hemodynamic, echocardiographic, and demographic profiles of patients with chronic thromboembolic pulmonary hypertension and atrial fibrillation: A multicenter cohort study

慢性血栓栓塞性肺动脉高压合并心房颤动患者的血流动力学、超声心动图和人口学特征:一项多中心队列研究

2025-04-010
OAAI